Navigation Links
Oregon Department of Human Services Selects APS Healthcare to Manage Expanded Statewide Medicaid Program
Date:5/28/2009

WHITE PLAINS, N.Y., May 28 /PRNewswire/ -- APS Healthcare, a leading provider of specialty healthcare solutions, has been selected by the Oregon Department of Human Services (DHS), Division of Medical Assistance Programs, to manage its statewide Medicaid disease and medical care management programs. The integrated program will assist Oregon's Medicaid and SCHIP fee-for-service clients to access healthcare, minimize catastrophic health events and improve health outcomes through education and interventions that help promote behavior change.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081105/NY44126LOGO )

"After a thorough review of APS Healthcare's service proposal and experience against our selection criteria, we determined APS was the best choice to meet the unique needs of our population," said Walter Shaffer, MD, Medical Director, Oregon Division of Medical Assistance Programs, DHS. "This program will deliver critical health coordination services to Oregonians, improving their health status and reducing our overall healthcare expenditures."

The program emphasizes coordination of care and collaboration with local healthcare providers; as well as early intervention with clients at high risk for health issues. Eligible Oregonians can access a telephonic nurse advice line 24-hours-a-day which connects clients with referrals to essential community providers and facilitates the establishment of a medical home -- a primary care health provider who provides preventive medical services, and care for chronic or acute health issues. Locally-based nurse health coaches will monitor and evaluate the participant's progress, help eliminate barriers to care and encourage behavior changes which will improve health outcomes and reduce overall
'/>"/>

SOURCE APS Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
2. Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center
3. Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest
4. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
5. Details of Oregon Wine Regions First Luxury Inn, Spa Revealed at Groundbreaking Ceremony
6. The First Mega-Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery
7. New Report: Increasing Oregons Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
8. Big Tobacco Spends Record $12 Million to Deceive Oregon Voters
9. Tobacco Industry Puts Profits Before Kids in Defeating Oregon Ballot Initiative
10. TriWest Contributes $30,000 to Oregon National Guard Fund
11. Oregon researchers find trigger gene for muscle development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ts who have a prostate-specific antigen (PSA) valu...external beam radiation therapy (EBRT) are less li...d death, according to a study in the December 1 is...logy*Biology*Physics, the official journal of the ... PSA levels in a prostate cancer patient are moni...
(Date:12/2/2009)... National Pen ( www.pens.com ), a worldwide leadi...it is giving away 10,000 free business card pens. ...9 -- National Pen ( www.pens.com ), a worldwide le...y it is giving away 10,000 free business card pens...siness that no other company in the industry can d...
(Date:12/2/2009)... National Race Series to increase awareness of pr...n the importance of early detection , ...- Men, women, families, friends and neighbors &nda...articipate in the Rudolph Ramble 5K. The Rudolph ...ies , which was launched by the Prostate Conditio...
(Date:12/2/2009).... 2 The American Health...ectors today announced Alan F. Dowling, PhD, will ...ealth information management (HIM) leader. Dr. Do...cludes academia, systems management, strategic exp...t executive leadership. He is scheduled to take o...
(Date:12/2/2009)... - 4 State Campaign Features Small Business Owners...and Would Kill Jobs ,, WASHINGTON, Dec. 2 /PRN... summit scheduled for Thursday, Keeping Small Busi...ty, today announced a new $1 million 4 state TV ad... current health care legislation on small business...
Breaking Medicine News(10 mins):Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4
... of "Nicole,s Law" designed to ...an 28 Are local seniors,safe at Atria Senior Livi...,Assisted Living and SEIU Healthcare were asking a...ors that would warn,residents and staff of the pre...
...United Kingdom and the United States has revealed ...her to the next generation in a mouse model system... Genetics*, shows for the first time how mitochond...ngines present in each cell that produce adenosine...
...OWS, Ill., Jan. 26 The American,Society for Derma...rganization of leaders in the field of cosmetic an...e petition filed by Public Citizen with the,U.S. F...d use by trained physicians, believes that there i...
...f the,Chicago-based Health Capital Group, urged ho... look at their existing debt instruments, their,ob...ight of recent capital,market developments., Prob... in both debt pricing and access to capital challe...
... findings, experts say , , FRIDAY, Jan. 25...E and lutein could lower a woman,s risk of sight-r... observational study included more than 35,000 wom...of cataracts," said lead author William G. Christe...
...archers from Mayo Clinic in Rochester, Minnesota, ...c stents (SEPSs) in the treatment of benign esopha...in frequent stent migration and few cases of long-...or the use of SEPSs. The study appears in the Janu...
Other Medicine News:Health News:Activists Raise Alarm for Seniors, Deliver Carbon Monoxide Detectors to Atria Marland Place 2Health News:In silico modeling helps predict severity of mitochondrial disease 2Health News:American Society for Dermatologic Surgery Supports Current Labeling of Allergan's Botox(R) Products 2Health News:Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans 2Health News:Vitamin E, Lutein May Fight Cataracts 2Health News:Vitamin E, Lutein May Fight Cataracts 3Health News:Study examines self-expanding plastic stents in the treatment of benign esophageal conditions 2Health News:Study examines self-expanding plastic stents in the treatment of benign esophageal conditions 3
(Date:12/2/2009)...e-FirstCall/ -- Cardinal Health today announced th... directors, effective immediately. ,, Cox, 52, ...nd president of global pharmaceuticals at Schering...mpany at the close of its merger with Merck last m... Cox served as president of Pharmacia Corp.,s glob...
(Date:12/2/2009)...ecember 2 DermaGen AB - part of th...ling company "Pergamum" -,today announced that Der...nical Phase I/IIa study. DermaGen AB is developing... atopic dermatitis. Atopic dermatitis is a chronic...skin,s weakened barrier,function make patients sus...
(Date:12/2/2009)...er 2 Cardio Vascular,Med...f advanced,cardiovascular surgery technology, toda...approved a one-for-three forward stock split, in t...cular Medical Device shareholders. , The ...date the stock,split will be payable and the relat...
Breaking Medicine Technology:Cardinal Health Names Carrie Cox to Board of Directors 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Cardio Vascular Medical Device Announces Forward Stock Split 2NOSCAR 28R 29 Increases NOTES 28R 29 Research with Olympus Medical Systems Corporation Grant 51394 1NOSCAR 28R 29 Increases NOTES 28R 29 Research with Olympus Medical Systems Corporation Grant 51394 2NOSCAR 28R 29 Increases NOTES 28R 29 Research with Olympus Medical Systems Corporation Grant 51394 3NOSCAR 28R 29 Increases NOTES 28R 29 Research with Olympus Medical Systems Corporation Grant 51394 4UK Smoking Ban Fuels Rise In Surgery 51391 1UK Smoking Ban Fuels Rise In Surgery 51391 2Healthy Directions LLC Welcomes Jim Barch as New Chief Executive Officer 51388 1Healthy Directions LLC Welcomes Jim Barch as New Chief Executive Officer 51388 2Healthy Directions LLC Welcomes Jim Barch as New Chief Executive Officer 51388 3
...at works within minutes, upon European ...une 2 Schering-Plough,Corporation (NYSE: SGP ) t...ducts for Human Use (CHMP) of the European Medicin...madex for routine reversal of the muscle,relaxants...al of rocuronium,in adults, and for routine revers...
...1 significantly increased efficacy of, letrozole ...tive breast cancer...come a major pathway of resi...lore potential of RAD001 in breast cancer by ...EAST HANOVER, N.J., June 2 Early proof-of-concept...
Other Medicine Technology:European Union's CHMP Issues Positive Opinion on Sugammadex 2European Union's CHMP Issues Positive Opinion on Sugammadex 3European Union's CHMP Issues Positive Opinion on Sugammadex 4European Union's CHMP Issues Positive Opinion on Sugammadex 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 2Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 3Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 4Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 6Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 7Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 8Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 9
CHECK-FLO Performer Introducer Sets
TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System
Wiseguide Guide Catheter
Convoy Catheter Introducer Sheaths
Medicine Products: